Assessment of Clinical Complications and Treatment Approaches in Non-Transfusion-Dependent α- and β-Thalassemia Patients Compared to Matched Controls: A Retrospective Analysis Utilizing Administrative Claims Data in the United States - Takeaways - MDSpire

Assessment of Clinical Complications and Treatment Approaches in Non-Transfusion-Dependent α- and β-Thalassemia Patients Compared to Matched Controls: A Retrospective Analysis Utilizing Administrative Claims Data in the United States

  • By

  • Arielle L. Langer

  • Amey Rane

  • Keely S. Gilroy

  • Jing Zhao

  • Louise Lombard

  • Carolyn R. Lew

  • Sujit Sheth

  • March 30, 2026

  • 0 min

Share

  • 1

    Non-transfusion-dependent thalassemia (NTDT) significantly impacts patient quality of life due to various clinical complications.

  • 2

    A study analyzed NTDT patients in the US, revealing higher complication rates compared to matched controls.

  • 3

    Patients with NTDT had significantly higher rates of malignancy, cardiovascular disease, liver disease, and gallstones.

  • 4

    Only 18.8% of NTDT patients received transfusions, and a mere 4.0% were treated with oral chelators.

  • 5

    The findings highlight the need for effective treatments to address complications associated with NTDT.

Original Source(s)

Assessment of Clinical Complications and Treatment Approaches in Non-Transfusion-Dependent α- and β-Thalassemia Patients Compared to Matched Controls: A Retrospective Analysis Utilizing Administrative Claims Data in the United States

  • by Arielle L. Langer, Amey Rane, Keely S. Gilroy, Jing Zhao, Louise Lombard, Carolyn R. Lew, Sujit Sheth

  • March 30, 2026

Related Content

Effect of preoperative anemia on surgical outcomes in endonasal transsphenoidal surgery for pituitary adenoma: a matched-cohort study

Crossing the line: blood transfusion thresholds in ECMO

Merging evans syndrome with mucopolysaccharidosis type II: a case report